PMID- 36119163
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220920
IS  - 2249-4863 (Print)
IS  - 2278-7135 (Electronic)
IS  - 2249-4863 (Linking)
VI  - 11
IP  - 6
DP  - 2022 Jun
TI  - Correlation of iron levels with glycemia and microvascular complications among 
      type II diabetes mellitus patients in Najran university hospital.
PG  - 2690-2694
LID - 10.4103/jfmpc.jfmpc_545_21 [doi]
AB  - BACKGROUND: Diabetes is influenced by changes in the body's iron levels. Because 
      iron deficiency anemia is common in diabetes, this study examines the link 
      between iron, glycemic control, and complication in patients with type 2 diabetes 
      mellitus (T2DM). METHODS: The study is a cross-sectional study conducted from 
      October 2019 to June 2020 at Najran university hospital in the Najran area, Saudi 
      Arabia. All T2DM patients (N = 201) during the study were recruited by simple 
      random sampling. A checklist was completed to extract the study variables from 
      each patient's medical record. RESULTS: There is a positive poor correlation 
      between hemoglobin (Hb) and diabetic foot (r = 0.186, P < 0.05), but not with 
      other diabetic microvascular complications (i.e., retinopathy, nephropathy, and 
      peripheral neuropathy) or glycemic indicators fasting blood sugar, random blood 
      sugar and hemoglobin A1C (i.e., FBS, RBS, and HbA1C). No link is found between 
      ferritin and glycemic indicators or diabetic microvascular complications. 
      CONCLUSION: The study suggests that particular attention be paid to regular 
      monitoring of iron levels before modifying the treatment plans for type 2 
      diabetes mellitus (T2DM) patients. It raises critical inquiry about the reality 
      of iron role in diabetes mellitus either in pathogenesis or treatment. It 
      recommends accurately assessing body iron status with careful interpretation for 
      better clinical judgment, encouraging large-scale and long-term epidemiological 
      as well as interventional trials examining the effect of lowering iron in 
      controlling glycemia.
CI  - Copyright: (c) 2022 Journal of Family Medicine and Primary Care.
FAU - Alqahtani, Nasser
AU  - Alqahtani N
AD  - Family and Community Medicine Department, Faculty of Medicine, Najran University, 
      Najran, Kingdom of Saudi Arabia.
FAU - Ghazwani, Eisa Y
AU  - Ghazwani EY
AD  - Family and Community Medicine Department, Faculty of Medicine, Najran University, 
      Najran, Kingdom of Saudi Arabia.
FAU - Al-Qahtani, Awad M
AU  - Al-Qahtani AM
AD  - Family and Community Medicine Department, Faculty of Medicine, Najran University, 
      Najran, Kingdom of Saudi Arabia.
FAU - Elmahboub, Randah A
AU  - Elmahboub RA
AD  - Family and Community Medicine Department, Faculty of Medicine, Najran University, 
      Najran, Kingdom of Saudi Arabia.
LA  - eng
PT  - Journal Article
DEP - 20220630
PL  - India
TA  - J Family Med Prim Care
JT  - Journal of family medicine and primary care
JID - 101610082
PMC - PMC9480666
OTO - NOTNLM
OT  - Glycemic control
OT  - iron levels
OT  - microvascular complications
OT  - type 2 diabetes mellitus
COIS- There are no conflicts of interest.
EDAT- 2022/09/20 06:00
MHDA- 2022/09/20 06:01
PMCR- 2022/06/01
CRDT- 2022/09/19 04:23
PHST- 2021/03/21 00:00 [received]
PHST- 2021/12/17 00:00 [revised]
PHST- 2021/12/23 00:00 [accepted]
PHST- 2022/09/19 04:23 [entrez]
PHST- 2022/09/20 06:00 [pubmed]
PHST- 2022/09/20 06:01 [medline]
PHST- 2022/06/01 00:00 [pmc-release]
AID - JFMPC-11-2690 [pii]
AID - 10.4103/jfmpc.jfmpc_545_21 [doi]
PST - ppublish
SO  - J Family Med Prim Care. 2022 Jun;11(6):2690-2694. doi: 
      10.4103/jfmpc.jfmpc_545_21. Epub 2022 Jun 30.